33
17
th
Congress of the European Society for Sexual Medicine
Poster Presentations
P-01
Male Sexual Dysfunction
001 Periurethral injection of human adipose tissue
derived stem cells (hADSCs) prevents fibrosis
in a new rat model of urethral stricture
Fabio Castiglione, Italy
D. De Ridder, M. Albersen, S. Joniau, T. Biva
lacqua, A. Russo, F. Benigni, F. Montorsi,
P. Hedlund
002 Sexual arousal and sexual inhibition: Qualitative
study on italian men through focus group
Davide Pappalardo, Italy
M. Panzeri
003 Attitudes, self-esteem and sexual dysfunctions:
Prevalence and clinical features in a group of
young adult male
Jacopo Grisolaghi, Italy
R. S. Calabrò
004 Use of erectile dysfunction as a tool for early
diagnosis of cardiovascular diseases
Oleg Apolikhin, Russia
E. Efremov, S. Krasnyak
005 Penil severity scale can use to predict penil
shortening
Göksel Bayar, Turkey
M. Aydin, M. Kadihasanoglu, M. Kendirci
006 Evaluation of endothelial function by periphe-
ral arterial tonometry in patients with erectile
dysfunction
Rui Duarte Abreu, Portugal
007 The correlation between 25-OH-vitamin D and
erectile dysfunction (ED)
Ion Dumbraveanu, Republic of Moldova
V. Ghenciu, B. Balutel
008 Modifiable risk factors for cardiovascular disease
and erectile dysfunction – an analysis of the
patients knowledge in men with ischaemic heart
disease
Dariusz Kalka, Poland
L. Karpinski, Z. Domagala, J. Gebala, W. Bek,
L. Rusiecki, A. Grychowski, K. Jacyna, M. Ru
siecka, W. Pilecki
009 The analysis of the influence of the presence of
modifiable risk factors for cardiovascular disease
on the cardiologistis´ interest in erectile dysfun-
ction in patients with ischaemic heart disease
Dariusz Kalka, Poland
Z. Domagala, L. Karpinski, J. Gebala, L. Ru-
siecki, A. Bielous-Wilk, E. Sylwina-Krauz,
J. Dworak, W. Beck, W. Pilecki
010 An integral approach when facing age-related
health problems in men: What should we focus on?
Antonio Martin-Morales, Spain
R. Vozmediano Chicharro, V. Baena Gonzalez
011 Objectification and sexual dysfunctions in men
Antonio Prunas, Italy
A. Dakanalis, R. Bernorio, G. Mori
012 A protocol of duplex ultrasound after cavernous
injection of alprostadil
Pablo Velilla, Spain
A. Puerta, D. Garcia-Escudero, P. Samper,
A. Vilchez, J. P. Morga, J. Oñate, M. Torres,
L.O. Fontana
013 Healthy diet versus smoking impact on erectile
dysfunction patient's heart geometry and diasto-
lic performance; the good the bad and the final
countdown
Konstantinos Konstantinidis, Greece
A. Angelis, N. Ioakimidis, K. Makarounis,
K. Rokkas, P. Vrettas, M. Abdelrasoul,
C. Fasoulakis, C. Vlachopoulos, D. Tousoulis
014 Vascular, cardiac and erectile dysfunction; the
dangerous triad of atherosclerosis and the holi-
stic contribution of the Mediterranean diet in
the maintenance of cardiovascular health
Konstantinos Rokkas, Greece
C. Vlachopoulos, A. Angelis, N. Ioakimidis,
Z. Kratiras, P. Vrettas, F. Monpaient, K. Aggeli,
K. Konstantinidis, D. Tousoulis
015 Additional tadalafil therapy in tamsulosin non-
responders with LUTS/BPH
Vipan Bhatia, United Arab Emirates
016 Drug treatment for ED and PE patients
Bin Chen, China
T. Zhang, H. Wang, R. Chen, Y. Han, Y. Huang,
Y. Huang
017 Injectable testosterone undecanoate for the
treatment of hypogonadism
Elisa Maseroli, Italy
G. Corona, M. Maggi
018 Determining factors of the regenerative capacity
of the stromal vascular fraction
Marlene Quaade, Denmark
C. H. Jensen, D. C. Andersen, S. P. Sheikh
019 Improvement and stabilization of erectile func
tion, anthropometric and metabolic parame-
ters in hypogonadal men with type 2 diabetes
mellitus (T2DM) on long-term treatment with
testosterone undecanoate injections
Farid Saad, Germany
G. Doros, A. Haider, A. Traish
